Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs HAS✓SelectedUSD · HASGSK vs HAS performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs HAS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+109.4%
HAS return
+97.4%
Excess return
+11.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioHASExcessAlpha
1D-0.1%+0.4%-0.5%-0.1%
7D-1.3%+0.1%-1.4%-1.3%
30D+2.7%+22.5%-19.8%-0.3%
3M+2.7%+26.1%-23.4%-0.7%
6M+3.3%+29.1%-25.7%-0.7%
YTD+6.5%+50.9%-44.5%0.0%
1Y+10.7%+60.8%-50.1%+3.0%
3Y+64.4%+198.9%-134.6%+39.0%
5Y+46.7%+47.8%-1.1%+36.0%
10Y+109.4%+97.6%+11.8%+73.4%
All+109.4%+97.4%+11.9%+73.4%

Cumulative growth

Daily Returns

Daily percentage return beside HAS.

Daily Out/Under-Performance

Portfolio return minus HAS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded HAS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling